Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 86 | 0 | 0 | 0 | 0 |
| Cost of Goods | 279 | N/A | N/A | N/A | N/A |
| Gross Profit | -193 | N/A | N/A | N/A | N/A |
| Operating Expenses | 20,453 | 20,275 | 18,044 | 20,261 | 13,655 |
| Operating Income | -20,367 | -20,275 | -18,044 | -20,261 | -13,655 |
| Other Income | 982 | 1,107 | 1,249 | 876 | 975 |
| Pre-tax Income | -19,385 | -19,168 | -16,795 | -19,385 | -12,680 |
| Net Income Continuous | -19,385 | -19,168 | -16,795 | -19,385 | -12,680 |
| Net Income | $-19,385 | $-19,168 | $-16,795 | $-19,385 | $-12,680 |
| EPS Basic Total Ops | -0.29 | -0.28 | -0.25 | -0.33 | -0.21 |
| EPS Basic Continuous Ops | -0.29 | -0.28 | -0.25 | -0.33 | -0.21 |
| EPS Diluted Total Ops | -0.29 | -0.28 | -0.25 | -0.33 | -0.21 |
| EPS Diluted Continuous Ops | -0.29 | -0.28 | -0.25 | -0.33 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.28 | -0.25 | -0.27 | -0.21 |
| EBITDA(a) | $-20,111 | $-20,002 | $-17,761 | $-19,974 | $-13,361 |